NCT06829303

Brief Summary

Social cognition seems to develop atypically in autism, particularly in processes such as faces perception, joint attention and social information processing. In this sense, and using an Emotional Paradigm of Facial Expressions (EFP) with a Brain-Computer Interface (BCI) based on Electroencephalography (EEG), the investigators intend to evaluate its effectiveness as a medical device in Autism Spectrum Disorder (ASD), namely: improving 1) social skills and 2) reducing generalized anxiety, 3) improve error monitoring, and consequently verify 4) an increase in motivation. To this end, the investigators will test a gamified intervention (EFP), using personalized feedback in real time. In this gamified interface, there is an artificial agent that learns rules through Reinforcement Learning using the evoked potentials from the participant as they observe the agent's right or wrong actions. The hypothesis is that this approach allows, during the gamified task (EFP), not only the agent/interface to learn, but also the participant through operant conditioning and implicit scrutiny of errors, which makes it particularly interesting for disorders in which error monitoring processes are compromised, as in ASD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

February 3, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

1.5 years

First QC Date

February 3, 2025

Last Update Submit

July 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline to post-intervention in a computerized attention task (Subway Game)

    Responses consist on the time spent to complete 3 mazes, using computer mouse navigation. Responses are measured in seconds and the best outcomes correspond to the fastest responses.

    From baseline to the end of treatment (maximum of 8 weeks)

  • Change from baseline to post-intervention in the Anxiety Sub-Scale from "The Hospital Anxiety and Depression Scale"

    Participants scores ranges from 0 (best outcome) to 21 (worst outcome).

    From baseline to the end of treatment (maximum of 8 weeks).

Secondary Outcomes (3)

  • Change in error-monitoring in Emotional Facial Expression Paradigm (EFP) across intervention

    At each intervention session, from first to last (intervention lasts up to 8 weeks and starts within 2 weeks after baseline)

  • Change from baseline to post-intervention in the Interest/Enjoyment subscale of "Intrinsic Motivation Inventory (IMI)"

    From baseline to the end of treatment (maximum of 8 weeks)

  • Change from baseline to post-intervention in a computerized attention task (Subway Game - eye gaze)

    From baseline to the end of treatment (maximum of 8 weeks).

Other Outcomes (6)

  • Change in spelling accuracy in a Speller Task across intervention

    At each intervention session, from first to last (intervention lasts up to 8 weeks)

  • Change from baseline to post-intervention in the "Autism Treatment Evaluation Checklist (ATEC)"

    From baseline to the end of treatment (maximum of 8 weeks)

  • Change from baseline to post-intervention in total score of "Toronto Alexithymia Scale-20 (TAS-20)"

    From baseline to the end of treatment (maximum of 8 weeks)

  • +3 more other outcomes

Study Arms (2)

Experimental Arm

EXPERIMENTAL

Experimental Arm The experimental group (n=17) will undergo three sessions of BCI intervention up to a maximum of six sessions. The intervention will be applied once a week, during three weeks, minimum, up to six weeks, maximum. The final number of sessions to be completed was defined after piloting. It will consist on a gamified task to train social cognition and to explore its viability for error-monitoring using EEG based non-volitional neurofeedback. The intervention comprises two modules, a visual paradigm called 'Emotional Facial Expression Paradigm' (EFP), where the subject is asked to observe the movements of a facial expression, and an 'Intelligent Agent' that learns through Reinforcement Learning from participant's judgments to the actions of the Intelligent Agent.

Device: Emotional Facial Expression Paradigm (EFP)

Control Arm

OTHER

The control group (n=17) will undergo a minimum of three and up to six sessions of BCI control intervention. The control intervention will be applied once per week. It will consist on a gamified attention task of executive function training, through a P300 BCI non-invasive interface based on EEG. The task consists of a speller, in which the participant is asked to write a word, by sequentially focusing the attention on the necessary letters.

Device: Speller task

Interventions

The experimental intervention is a social cognition gamified training, through a software that implements communication between a participant and a computer, using a detection and classification algorithm based on EEG signal. The training consists of a visual stimulation model, specifically an emotional facial paradigm, where the subject is asked to observe the movements of a facial expression (referred to as cue image) expressing either happiness or sadness and to adapt the visual gaze according the cue image.

Experimental Arm

The control intervention is a executive function gamified training, through a software that implements communication between a participant and a computer, using a detection and classification algorithm based on the P300 EEG signal. The task consists of a speller, in which the participant is asked to write a word, by sequentially focusing the attention on the necessary letters.

Control Arm

Eligibility Criteria

Age16 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Participant is able and willing to give written informed consent/assent
  • Previous diagnosis of Autism Spectrum Disorder by a qualified clinician according to gold-standard instruments
  • Aged between 16 and 55 years old
  • Normal or corrected-to-normal vision

You may not qualify if:

  • Global Intelligence Quotient \<70
  • Dermatological diseases of the scalp
  • Concurrent neurofeedback therapy
  • Concomitant medication without a stable dosage for at least 4 weeks
  • History of seizures and/or epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ICNAS

Coimbra, 3000 548, Portugal

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Miguel Castelo-Branco

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

February 3, 2025

First Posted

February 17, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 1, 2025

Record last verified: 2025-07

Locations